Key Areas of Research: Tissue Repair: Healing and structural cell recovery Vascular Support: Angiogenesis and endothelial repair Inflammatory Regulation: Response modulation and cytokine balance Systemic Studies: Combined multi-pathway recovery response Collectively, these findings indicate the blends value for exploring mechanisms of accelerated recovery, tissue protection, and cellular adaptation under controlled conditions
Liposomal Glutathione Enhanced with PerfectAmino provides L-glutathionethe bodys master antioxidantin a liposomal matrix for optimal absorption and cellular delivery
5.3.2 Expanding Flavor Options SAG pairs perfectly with almost any flavor, including fruit, mint, and herbal flavors
Improves Cardiovascular Health: Oceania Research suggests it may help lower blood pressure and reduce oxidative stress and heart disease risk by promoting relaxation and stress relief (12)
Abbreviations 3D: Three-Dimensional 3 T3: Fibroblast Cell Line 5-FU: 5-Fluorouracil ABI-009: Nab-Sirolimus AIDS: Acquired Immunodeficiency Syndrome AML: Acute Myeloid Leukemia ATC: Anaplastic Thyroid Cancer ATP: Adenosine Triphosphate Ab: Antibody AlPcSCl: Aluminum Phthalocyanine Chloride AuCl: Tetrachloroaurate Ion AuNPs: Gold Nanoparticles BBB: BloodBrain Barrier BCG: Bacillus Calmette-Gurin BCLC: Barcelona Clinic Liver Cancer BIND-014: Prostate-Specific Membrane Antigen-Targeted Docetaxel Nanoparticles BS: -Sitosterol Caco-2 Bio-MOF: Bio-MetalOrganic Framework CBDCA: Carboplatin CDDP: Cisplatin CI: Confidence Interval CMC: Critical Micelle Concentration CNT: Carbon Nanotube CR: Complete Response CRC: Colorectal Cancer CRLX101: Camptothecin-Loaded Polymeric Nanoparticle CRT: Chemoradiotherapy CS: Chitosan CT: Computed Tomography Cu MOF: Copper MetalOrganic Framework ctDNA: Circulating Tumor DNA DCR: Disease Control Rate DCR-MYC: MYC-Targeting siRNA in Lipid Nanoparticles DFS: Disease-Free Survival DLT: Dose-Limiting Toxicity DOPC: Dioleoylphosphatidylcholine DPPC: Dipalmitoyl Phosphatidylcholine Den: Dendrimer Nanoparticles DoR: Duration of Response EFS: Event-Free Survival EGFR: Epidermal Growth Factor Receptor EMA: European Medicines Agency EPR: Enhanced Permeability and Retention FA: Folic Acid FDA: Food and Drug Administration FEC: Fluorouracil, Epirubicin, Cyclophosphamide FNPs: Iron Oxide Nanoparticles FRA: Folate Receptor-Alpha FUS: Focused Ultrasound FeNPs: Iron Oxide Nanoparticles FeO: Iron Oxide FeO NPs: Magnetic Iron Oxide Nanoparticles G 3 AE: Grade 3 or Higher Adverse Events GBM: Glioblastoma GSH: Glutathione GO: Graphene Oxide H1299: Lung Cancer Cell Lines H 2 O 2 : Hydrogen Peroxide HCC: Hepatocellular Carcinoma HER2: Human Epidermal Growth Factor Receptor 2 HMME: Hematoporphyrin Monomethyl Ether HNSCC: Head and Neck Squamous Cell Carcinoma HR: Hazard Ratio HSPC: Hydrogenated Soy Phosphatidylcholine HepG2: Liver Cancer HfO: Hafnium Oxide HIFU: High-Intensity Focused Ultrasound IC50: Inhibitory Concentration 50% ICIs: Immune Checkpoint Inhibitors IO: Immunotherapy IONPs: Iron Oxide Nanoparticles LAR: Long-Acting Release LHRH: Luteinizing Hormone-Releasing Hormone LNPs: Lipid Nanoparticles LTLD: Lyso-Thermosensitive Liposomal Doxorubicin LY01610: Liposomal Irinotecan Formulation mFOLFOX: Modified FOLFOX Chemotherapy Regimen (Fluorouracil, Leucovorin, Oxaliplatin) miRNA: MicroRNA MMP: Matrix Metalloproteinaise mOS: Median Overall Survival mPFS: Median Progression-Free Survival mRFS: Median Relapse-Free Survival mRNA: Messenger Ribonucleic Acid mTOR: Mammalian Target of Rapamycin MPR: Major Pathological Response MRI: Magnetic Resonance Imaging MSNs: Mesoporous Silica Nanoparticles MTD: Maximum Tolerated Dose MWCNTs: Multi-Walled Carbon Nanotubes MYC: Myelocytomatosis Viral Oncogene Homolog MoAb: Monoclonal Antibody NC-6004: Cisplatin-Containing Polymeric Nanoparticle NIR: Near-Infrared NK105: Micellar Paclitaxel Formulation NKTR-102: PEGylated Irinotecan NSCLC: Non-Small Cell Lung Cancer Nab-Paclitaxel: Nanoparticle Albumin-Bound Paclitaxel Nab-Sirolimus: Albumin-Bound Sirolimus ORR: Overall Response Rate OS: Overall Survival PBS: PhosphateBuffered Saline pCR: Pathological Complete Response PDT: Photodynamic Therapy PE: Primary Endpoint PEG: Polyethylene Glycol PET: Positron Emission Tomography PFS: Progression-Free Survival PLGA: Poly(Lactic-co-Glycolic Acid) PO: Primary Outcome PR: Partial Response PSMA: Prostate-Specific Membrane Antigen PXT: Paclitaxel PTT: Photothermal Therapy RES: Reticulo-Endothelial System RFS: Relapse-Free Survival RNA: Ribonucleic Acid RNAi: RNA Interference ROS: Reactive Oxygen Species RP2D: Recommended Phase 2 Dose RT: Radiotherapy SAE: Serious Adverse Event SCLC: Small Cell Lung Cancer SD: Stable Disease siRNA: Small Interfering RNA SPARC: Secreted Protein, Acidic and Rich in Cysteine SPIONs: Superparamagnetic Iron Oxide Nanoparticles SWCNT: Single-Walled Carbon Nanotube TME: Tumor Microenvironment US: Ultrasound References Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A
